Preclinical development of a humanized chimeric antigen receptor against B cell maturation antigen for multiple myeloma

Multiple myeloma is a prevalent and incurable disease, despite the development of new and effective drugs. The recent development of chimeric antigen receptor (CAR)-T cell therapy has shown impressive results in the treatment of patients with relapsed or refractory hematological B cell malignancies...

Full description

Bibliographic Details

Published in:	Haematologica
Main Authors:	Lorena Perez-Amill, Guillermo Suñe, Asier Antoñana-Vildosola, Maria Castella, Amer Najjar, Jaume Bonet, Narcis Fernández-Fuentes, Susana Inogés, Ascensión López, Clara Bueno, Manel Juan, Álvaro Urbano-Ispizua, Beatriz Martín-Antonio
Format:	Article
Language:	English
Published:	Ferrata Storti Foundation 2020-01-01
Online Access:	https://haematologica.org/article/view/9604